Interestingly, TAM-mediated LMP in antiestrogen sensitive and resistant breast cancer cells was abrogated and viability reduced upon co-treatment with 3-methyladenine (3-MA), an early-stage autophagy inhibitor, or chloroquine (CQ), a lysosomotropic agent that blocks autolysosomal turnover. The gene discussed is PDLIM7; the disease is breast cancer.